Human papillomavirus infection correlates with inflammatory stat3 signaling activity and IL-17 level in patients with colorectal cancer

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Li, Yi Xin ^a   Zhang, Lei ^a,b   Simayi, Dilixia ^a,c   Zhang, Nan ^a   Tao, Lin ^a   Yang, Lan ^a   Zhao, Jin ^a   Chen, Yun Zhao ^a   Li, Feng ^a   Zhang, Wen Jie ^a  

^a SHIHEZI UNIVERSITY   (China)

^b Changzhou Women and Children's Hospital   (China)

^c XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; INTERLEUKIN 17; STAT3 PROTEIN; STAT3 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER STAGING; CELL DIFFERENTIATION; CHINESE; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DNA EXTRACTION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PAPILLOMAVIRUS INFECTION; PROTEIN DENATURATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SEX DIFFERENCE; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; TUMOR MICROENVIRONMENT; CHINA; COLORECTAL TUMOR; COMPLICATION; METABOLISM; MIDDLE AGED;

HUMAN PAPILLOMAVIRUS;

CHINA; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INTERLEUKIN-17; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; STAT3 TRANSCRIPTION FACTOR;

EID: 84923324874     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0118391     Document Type: Article

References (49)

1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available: http://globocan.iarc.fr.
2. Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010; 116: 544-573. doi: 10.1002/cncr.24760 PMID: 19998273
3. Jemal A, Thun MJ, Ries LA, Howe HL, Weir HK, Center MM, et al. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst. 2008; 100: 1672-1694. doi: 10.1093/jnci/djn389 PMID: 19033571
4. Gagliani N, Hu B, Huber S, Elinav E, Flavell RA. The Fire Within: Microbes Inflame Tumors. Cell. 2014; 157: 776-783. doi: 10.1016/j.cell.2014.03.006 PMID: 24813605
5. Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer. 2011; 11: 9-22. doi: 10.1038/nrc2982 PMID: 21160525
6. Veldhuijzen NJ, Snijders PJ, Reiss P, Meijer CJ, van de Wijgert JH. Factors affecting transmission of mucosal human papillomavirus. Lancet Infect Dis. 2010; 10: 862-874. doi: 10.1016/S1473-3099(10)70190-0 PMID: 21075056
7. Chen TH, Huang CC, Yeh KT, Chang SH, Chang SW, Sung WW, et al. Human papilloma virus 16 E6 oncoprotein associated with p53 inactivation in colorectal cancer. World J Gastroenterol. 2012; 18: 4051-4058. doi: 10.3748/wjg.v18.i30.4051 PMID: 22912557
8. Yavuzer D, Karadayi N, Salepci T, Baloglu H, Dabak R, Bayramicli OU. Investigation of human papillomavirus DNA in colorectal carcinomas and adenomas. Med Oncol. 2011; 28: 127-132. doi: 10.1007/s12032-010-9416-4 PMID: 20082157
9. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010; 140: 883-899. doi: 10.1016/j.cell.2010.01.025 PMID: 20303878
10. Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer. 2009; 9: 798-809. doi: 10.1038/nrc2734 PMID: 19851315
11. Grivennikov SI, Karin M. Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev. 2010; 21: 11-19. doi: 10.1016/j.cytogfr.2009.11.005 PMID: 20018552
12. Murugaiyan G, Saha B. Protumor vs antitumor functions of IL-17. J Immunol. 2009; 183: 4169-4175. doi: 10.4049/jimmunol.0901017 PMID: 19767566
13. Chae WJ, Gibson TF, Zelterman D, Hao L, Henegariu O, Bothwell AL. Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis. Proc Natl Acad Sci.2010; 107: 5540-5544. doi: 10.1073/pnas.0912675107 PMID: 20212110
14. Wu D, Wu P, Huang Q, Liu Y, Ye J, Huang J. Interleukin-17: A Promoter in Colorectal Cancer Progression. Clin Dev Immunol. 2013; 2013: 436307. doi: 10.1155/2013/436307 PMID: 24382972
15. Mukherjee S, Allen RM, Lukacs NW, Kunkel SL, Carson WF IV. STAT3 mediated IL-17 production by post-septic T cells exacerbates viral immunopathology of the lung. Shock. 2012; 38: 515-523. doi: 10.1097/SHK.0b013e31826f862c PMID: 23042197
16. Abudukadeer A, Ding Y, Niyazi M, Ababaikeli A, Abudula A. Distribution of HPV genotypes in uterine cervical lesions among the Uighur women in Xinjiang province of China. Eur J Gynaecol Oncol. 2010; 31: 315-318. PMID: 21077477
17. Zhu Y, Ding X, Wang Y, Gao J, Shen M, He J. Human papillomavirus infections in women with clinical gynaecological diseases in southwest China. Int J STD AIDS. 2012; 23: e1-e5. doi: 10.1258/ijsa.2009.009168 PMID: 23104757
18. Li BH, Xu SB, Li F, Zou XG, Saimaiti A, Simayi D. Stat6 activity-related Th2 cytokine profile and tumor growth advantage of human colorectal cancer cells in vitro and in vivo. Cell signal. 2012; 24: 718-725. doi: 10.1016/j.cellsig.2011.11.005 PMID: 22108090
19. Couto JP, Daly L, Almeida A, Knauf JA, Fagin JA, Sobrinho-Simoes M, et al. STAT3 negatively regulates thyroid tumorigenesis. Proc Natl Acad Sci. 2012; 109: E2361-E2370. doi: 10.1073/pnas.1201232109 PMID: 22891351
20. Egner JR. AJCC cancer staging manual. JAMA. 2010; 304: 1726-1727.
21. Antonic V, Stojadinovic A, Kester KE, Weina PJ, Brücher BL, Protic M, et al. Significance of infectious agents in colorectal cancer development. J Cancer. 2013; 4: 227. doi: 10.7150/jca.5835 PMID: 23459622
22. Zhang WJ, Li F, Wang YH, Simayi D, Saimaiti A, Zou XG, et al. The case for semi-mandatory HPV vaccination in China. Nat Biotechnol. 2013; 31: 590-591. doi: 10.1038/nbt.2631 PMID: 23839139
23. Baandrup L, Thomsen LT, Olesen TB, Andersen KK, Norrild B, Kjaer SK. The prevalence of human papillomavirus in colorectal adenomas and adenocarcinomas: A systematic review and meta-analysis. Eur J Cancer. 2014; 50: 1446-1461. doi: 10.1016/j.ejca.2014.01.019 PMID: 24560489
24. Damin D, Ziegelmann P, Damin A. Human papillomavirus infection and colorectal cancer risk: a meta-analysis. Colorectal Dis. 2013; 15: e420-e428. doi: 10.1111/codi.12257 PMID: 23895733
25. Svahn MF, Faber MT, Christensen J, Norrild B, Kjaer SK. Prevalence of human papillomavirus in epithelial ovarian cancer tissue. A meta-analysis of observational studies. Acta Obstet Gynecol Scand. 2014; 93: 6-19. doi: 10.1111/aogs.12254 PMID: 24033121
26. Li N, Yang L, Zhang Y, Zhao P, Zheng T, Dai M. Human papillomavirus infection and bladder cancer risk: a meta-analysis. J Infect Dis. 2011; 204: 217-223. doi: 10.1093/infdis/jir248 PMID: 21673031
27. Syrjänen K. Detection of human papillomavirus in lung cancer: systematic review and meta-analysis. Anticancer Res. 2012; 32: 3235-3250. PMID: 22843898
28. Li N, Bi X, Zhang Y, Zhao P, Zheng T, Dai M. Human papillomavirus infection and sporadic breast carcinoma risk: a meta-analysis. Breast Cancer Res Treat. 2011; 126: 515-520. doi: 10.1007/s10549-010-1128-0 PMID: 20740311
29. McGregor B, Byrne P, Kirgan D, Albright J, Manalo P, Hall M. Confirmation of the association of human papillomavirus with human colon cancer. Am J Surg. 1993; 166: 738-742. PMID: 8273860
30. Elgui de Oliveira D. DNA viruses in human cancer: an integrated overview on fundamental mechanisms of viral carcinogenesis. Cancer lett. 2007; 247: 182-196. PMID: 16814460
31. Chen AC, Keleher A, Kedda MA, Spurdle AB, McMillan NA, Antonsson A. Human papillomavirus DNA detected in peripheral blood samples from healthy Australian male blood donors. J Med Virol. 2009; 81: 1792-1796. doi: 10.1002/jmv.21592 PMID: 19697401
32. Chiou HL, Wu MF, Liaw YC, Cheng YW, Wong RH, Chen CY, et al. The presence of human papillomavirus type 16/18 DNA in blood circulation may act as a risk marker of lung cancer in Taiwan. Cancer. 2003; 97: 1558-1563. PMID: 12627521
33. Cason J, Mant CA. High-risk mucosal human papillomavirus infections during infancy & childhood. J Clin Virol. 2005; 32: 52-58.
34. Mercer J, Helenius A. Virus entry by macropinocytosis. Nat Cell Biol. 2009; 11: 510-520. doi: 10.1038/ncb0509-510 PMID: 19404330
35. Miyahara Y, Odunsi K, Chen W, Peng G, Matsuzaki J, Wang RF. Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer. Proc Natl Acad Sci U S A. 2008; 105: 15505-15510. doi: 10.1073/pnas.0710686105 PMID: 18832156
36. Benevides L, Cardoso CR, Tiezzi DG, Marana HR, Andrade JM, Silva JS. Enrichment of regulatory T cells in invasive breast tumor correlates with the upregulation of IL-17A expression and invasiveness of the tumor. Eur J Immunol. 2013; 43: 1518-1528. doi: 10.1002/eji.201242951 PMID: 23529839
37. Lv L, Pan K, Li XD, She KL, Zhao JJ, Wang W, et al. The accumulation and prognosis value of tumor infiltrating IL-17 producing cells in esophageal squamous cell carcinoma. PLoS One. 2011; 6: e18219. doi: 10.1371/journal.pone.0018219 PMID: 21483813
38. Zhuang Y, Peng LS, Zhao YL, Shi Y, Mao XH, Chen W, et al. CD8(+) T Cells That Produce Interleukin-17 Regulate Myeloid-Derived Suppressor Cells and Are Associated With Survival Time of Patients With Gastric Cancer. Gastroenterology. 2012; 143: 951-962. e8. doi: 10.1053/j.gastro.2012.06.010 PMID: 22710190
39. Le Gouvello S, Bastuji-Garin S, Aloulou N, Mansour H, Chaumette M-T, Berrehar F, et al. High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas. Gut. 2008; 57: 772-779. PMID: 17965063
40. Guirnalda PD, Paterson Y. Vaccination with immunotherapeutic Listeria monocytogenes induces IL-17+ γδ T cells in a murine model for HPV associated cancer. Oncoimmunology. 2012; 1: 822. PMID: 23162749
41. Chang YH, Yu CW, Lai LC, Tsao CH, Ho KT, Yang SC, et al. Up-regulation of interleukin-17 expression by human papillomavirus type 16 E6 in nonsmall cell lung cancer. Cancer. 2010; 116: 4800-4809. doi: 10.1002/cncr.25224 PMID: 20578176
42. Zhang ZX, Xu CL, Cao YT. Correlations between human papillomavirus testing and Interleukin-17 in cervical exfoliated cells with cervical cancer and its clinical significonce. Chinese Journal of Laboratory Diagnosis. 2012; 2: 022.
43. Shukla S, Shishodia G, Mahata S, Hedau S, Pandey A, Bhambhani S, et al. Aberrant expression and constitutive activation of STAT 3 in cervical carcinogenesis: implications in high-risk human papillomavirus infection. Mol Cancer. 2010; 9: 282-282. doi: 10.1186/1476-4598-9-282 PMID: 20977777
44. Sobti R, Singh N, Hussain S, Suri V, Bharti A, Das BC. Overexpression of STAT3 in HPV-mediated cervical cancer in a north Indian population. Mol Cell Biochem. 2009; 330: 193-199. doi: 10.1007/s11010-009-0133-2 PMID: 19421717
45. Grivennikov SI, Wang K, Mucida D, Stewart CA, Schnabl B, Jauch D, et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature. 2012; 491: 254-258. doi: 10.1038/nature11465 PMID: 23034650
46. Tosolini M, Kirilovsky A, Mlecnik B, Fredriksen T, Mauger S, Bindea G, et al. Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. Cancer Res. 2011; 71: 1263-1271. doi: 10.1158/0008-5472.CAN-10-2907 PMID: 21303976
47. Kryczek I, Wei S, Zou L, Altuwaijri S, Szeliga W, Kolls J, et al. Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. J Immunol. 2007; 178: 6730-6733. PMID: 17513719
48. Muranski P, Restifo NP. Essentials of Th17 cell commitment and plasticity. Blood. 2013; 121: 2402-2414. doi: 10.1182/blood-2012-09-378653 PMID: 23325835
49. Alizadeh D, Trad M, Hanke NT, Larmonier CB, Janikashvili N, Bonnotte B, et al. Doxorubicin eliminates myeloid-derived suppressor cells and enhances the efficacy of adoptive T-cell transfer in breast cancer. Cancer Res. 2014; 74: 104-118. doi: 10.1158/0008-5472.CAN-13-1545 PMID: 24197130